MoneyWorks4Me

The sales for the June 2026 quarter moved up 29.73% to Rs. 6827.90 millions as compared to Rs. 5263.10 millions during the corresponding quarter last year.The Company to register a -32.06%  fall in the net profit for the quarter ended June 2026.A decline of 581.70 millions was observed in the OP in the quarter ended June 2026 from 923.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6827.90 5263.10 29.73 6827.90 5263.10 29.73 22755.80 17162.90 32.59
Other Income 92.30 112.40 -17.88 92.30 112.40 -17.88 284.90 406.30 -29.88
PBIDT 581.70 923.50 -37.01 581.70 923.50 -37.01 2905.20 2946.00 -1.38
Interest 19.50 7.20 170.83 19.50 7.20 170.83 44.90 14.60 207.53
PBDT 559.80 912.70 -38.67 559.80 912.70 -38.67 2807.80 1963.50 43.00
Depreciation 52.30 165.70 -68.44 52.30 165.70 -68.44 285.80 399.90 -28.53
PBT 507.50 747.00 -32.06 507.50 747.00 -32.06 2522.00 1563.60 61.29
TAX 128.20 188.70 -32.06 128.20 188.70 -32.06 646.80 406.20 59.23
Deferred Tax 19.50 -32.30 -160.37 19.50 -32.30 -160.37 52.60 -199.20 -126.41
PAT 379.30 558.30 -32.06 379.30 558.30 -32.06 1875.20 1157.40 62.02
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 8.52 17.55 -51.45 8.52 17.55 -51.45 12.77 17.16 -25.62

Astrazeneca Pharma Share Price

7925.00 -21.00 (-0.26%)
12-Aug-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1932.70
Dr. Reddys Labs. 1200.00
Cipla 1465.00
Lupin 2251.00
Zydus Lifesciences 1193.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: